Industrial development of PhoS-Istos project

Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.

English Channel swimming and pleural cancer

On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.

Enrollment phase of INDYGO is now successfully achieved

After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial

Analysis phase of PHOS-ISTOS clinical trial is now achieved

This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.

Rare diseases foundation and OncoThAI

OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord

Photodynamic Therapy and OncoThAI illustrated in Nature journal

The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal

Authorizations for the PAGETEX clinical trial

 The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.

End of the evaluation of the PHOSISTOS® project

Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission

Start of the PAGETEX clinical trial

The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.

Meeting to set up the BUBOLight® clinical trial

The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]


Notice: Undefined index: HTTP_REFERER in /home/dgecukh/www/templates/oncothai/html/com_tags/tag/default_items.php on line 143

Back